Huang Luqi, President of the China Academy of Chinese Medical Sciences, received the second National Award for Excellence in Innovation for his contribution during the prevention and control of the novel coronavirus disease (COVID-19), on May 30.

During the outbreak of COVID-19, Huang led the first traditional Chinese medicine (TCM) team to Wuhan, the country's hardest-hit city. As a member of the National Committee of the Chinese People's Political Consultative Conference, he suggested building platforms for research on the combination of TCM and Western medicines for infectious disease prevention and control during this year's Two Sessions, the annual meetings of the national legislature and the top political advisory body.

The award is endorsed by the Central Government for scientific and technological workers' outstanding achievements and research teams.